Position in SNWV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$665,750
-$451,757 QoQ
Shares Held
38,505
+2.8% QoQ
Ownership
0.448%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNWV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. SNWV ranks #72 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
14,505,201 | $1,489,248,984 | |
| 2 | BSX |
Boston Scientific Corp
|
18,891,624 | $1,185,449,403 | |
| 3 | SYK |
Stryker Corp
|
2,669,835 | $877,281,079 | |
| 4 | MDT |
Medtronic plc
|
5,600,590 | $485,291,119 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,082,050 | $406,970,562 | |
| 6 | PEN |
Penumbra Inc
|
720,575 | $236,615,212 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,266,138 | $232,483,701 | |
| 8 | DXCM |
Dexcom Inc
|
3,043,635 | $191,140,276 |
All Filings in SNWV
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $665,750 | 38,505 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,117,507 | 37,450 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,615,729 | 69,790 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $337,394 | 9,539 | Shares | Defined | 2025-06-27 | |
| No filing history on record for this holder in this stock. | ||||||